{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:11:54Z","timestamp":1791357114259,"version":"4.3.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.jad.2010.08.032","type":"journal-article","created":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T04:55:13Z","timestamp":1285908913000},"page":"19-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder"],"prefix":"10.1016","volume":"127","author":[{"given":"Michael","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"El-Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Datto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Szamosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2010.08.032_bb0005","first-page":"1","article-title":"Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association","volume":"157","author":"American Psychiatric Association","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl 6","key":"10.1016\/j.jad.2010.08.032_bb0010","first-page":"9","article-title":"Symptoms of fatigue and sleepiness in major depressive disorder","volume":"67","author":"Baldwin","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2010.08.032_bb0015","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4088\/JCP.08m04629","article-title":"Extended release quetiapine fumarate as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study","volume":"70","author":"Bauer","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2010.08.032_bb0020","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4088\/JCP.v68n0604","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study","volume":"68","author":"Berman","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2010.08.032_bb0025","doi-asserted-by":"crossref","unstructured":"Bortnick, B., El-Khalili, N., Banov, M., Adson, D., Datto, C., Raines, S., Earley, W., Eriksson, H. 2010. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study. J Affect Disord. (Aug 4, Electronic publication ahead of print).","DOI":"10.1016\/j.jad.2010.06.031"},{"key":"10.1016\/j.jad.2010.08.032_bb0030","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1185\/030079904125004510","article-title":"Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials","volume":"20","author":"Buckley","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2010.08.032_bb0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2010.08.032_bb0040","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2010.08.032_bb0045","series-title":"Poster presented at the 161st Annual Meeting of the American Psychiatric Association, Washington, DC, USA, May 3\u20138","article-title":"Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar mania","author":"Cutler","year":"2008"},{"key":"10.1016\/j.jad.2010.08.032_bb0050","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4088\/JCP.08m04592","article-title":"Extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study","volume":"70","author":"Cutler","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2010.08.032_bb0055","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.clinthera.2009.03.002","article-title":"Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects","volume":"31","author":"Datto","year":"2009","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jad.2010.08.032_bb0060","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/00003088-200140070-00003","article-title":"Clinical pharmacokinetics of quetiapine: an atypical antipsychotic","volume":"40","author":"DeVane","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jad.2010.08.032_bb0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1185\/030079906X162809","article-title":"Quetiapine augmentation of treatment-resistant depression: a comparison with lithium","volume":"23","author":"Doree","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"issue":"4","key":"10.1016\/j.jad.2010.08.032_bb0070","first-page":"332","article-title":"Double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder (MDD)","volume":"12","author":"Earley","year":"2008","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.jad.2010.08.032_bb0075","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1017\/S1461145710000015","article-title":"Extended release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment \u2014 a multicentre, randomized, double-blind, placebo-controlled study","volume":"13","author":"El-Khalili","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2010.08.032_bb0080","first-page":"321","article-title":"Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2010.08.032_bb0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0193-953X(05)70283-5","article-title":"Definition and epidemiology of treatment-resistant depression","volume":"19","author":"Fava","year":"1996","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.jad.2010.08.032_bb0090","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1176\/ajp.2006.163.7.1161","article-title":"A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report","volume":"163","author":"Fava","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl 4","key":"10.1016\/j.jad.2010.08.032_bb0095","doi-asserted-by":"crossref","first-page":"S401","DOI":"10.1016\/S0924-977X(07)70598-9","article-title":"Quetiapine's antidepressant properties: direct & indirect pharmacologic actions on norepinephrine & serotonin receptors","volume":"17","author":"Goldstein","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Suppl 2","key":"10.1016\/j.jad.2010.08.032_bb0100","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/j.eurpsy.2008.01.325","article-title":"Preclinical mechanisms for the broad spectrum of antipsychotic, antidepressant and mood stabilizing properties of Seroquel","volume":"23","author":"Goldstein","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2010.08.032_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.jad.2010.08.032_bb0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.7326\/0003-4819-143-6-200509200-00006","article-title":"Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder","volume":"143","author":"Hansen","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2010.08.032_bb0115","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/sj.npp.1301646","article-title":"N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT(1A) agonist, as a putative mediator of quetiapine's antidepressant activity","volume":"33","author":"Jensen","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2010.08.032_bb0120","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4088\/JCP.v68n0603","article-title":"Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"68","author":"Kahn","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2010.08.032_bb0125","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2010.08.032_bb0130","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.jad.2010.08.032_bb0135","doi-asserted-by":"crossref","unstructured":"Liebowitz, M., Lam, R.W., Lepola, U., Datto, C., Sweitzer, D., Eriksson, H.A., 2010. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment of major depressive disorder (MDD): a randomized, placebo-controlled trial. Depress. Anxiety (Aug 23, Electronic publication ahead of print).","DOI":"10.1002\/da.20740"},{"key":"10.1016\/j.jad.2010.08.032_bb0140","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-147-9-200711060-00003","article-title":"Risperidone for treatment-refractory major depressive disorder: a randomized trial","volume":"147","author":"Mahmoud","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2010.08.032_bb0145","series-title":"Poster NR250 presented at the American Psychiatric Association 159th Annual Meeting, Toronto, Canada, 20\u201325 May","article-title":"Quetiapine combination for treatment-resistant depression","author":"Mattingly","year":"2006"},{"key":"10.1016\/j.jad.2010.08.032_bb0150","doi-asserted-by":"crossref","unstructured":"McElroy, S., Young, A.H., Carlsson, A., Olausson, B., Nordenhem, A., Paulsson, B., Brecher, M. 2008. A double-blind, placebo-controlled study with acute and continuation phase of quetiapine and paroxetine in adults with bipolar depression (EMBOLDEN II), Bipolar Disord 10 (S1), 59.","DOI":"10.1016\/j.eurpsy.2008.01.451"},{"key":"10.1016\/j.jad.2010.08.032_bb0155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/da.20275","article-title":"Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety and residual depressive symptoms: a randomized, placebo-controlled pilot study","volume":"24","author":"McIntyre","year":"2007","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2010.08.032_bb0160","first-page":"10S","article-title":"The human cost of not achieving full remission in depression","volume":"49","author":"McIntyre","year":"2004","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2010.08.032_bb0165","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2010.08.032_bb0170","series-title":"Depression: the Treatment and Management of Depression in Adults","year":"2009"},{"key":"10.1016\/j.jad.2010.08.032_bb0175","series-title":"Manual for the ECDEU Assessment Battery","first-page":"1","article-title":"CGI: clinical global impressions","year":"1970"},{"issue":"Suppl 8","key":"10.1016\/j.jad.2010.08.032_bb0180","first-page":"17","article-title":"Prevalence and management of treatment-resistant depression","volume":"68","author":"Nemeroff","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2010.08.032_bb0185","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1016\/S0924-977X(08)70352-3","article-title":"PET-measured occupancy of the NET by extended release quetiapine fumarate (quetiapine XR) in brains of healthy subjects","volume":"18","author":"Nyberg","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2010.08.032_bb0190","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4088\/JCP.v68n0602","article-title":"Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis","volume":"68","author":"Papakostas","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2010.08.032_bb0195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1192\/bjp.bp.105.018325","article-title":"Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder: systematic review","volume":"189","author":"Ruh\u00e9","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2010.08.032_bb0200","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4088\/JCP.v67n1203","article-title":"Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review","volume":"67","author":"Ruh\u00e9","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2010.08.032_bb0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1176\/appi.ajp.160.2.237","article-title":"Depression, IV: STAR*D treatment trial for depression","volume":"160","author":"Rush","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2010.08.032_bb0210","unstructured":"Seroquel XR (quetiapine fumarate) Extended-Release Tablets \u2014 US prescribing information. 2010. Available at: http:\/\/www1.astrazeneca-us.com\/pi\/seroquelxr.pdf (accessed April 23, 2010)."},{"key":"10.1016\/j.jad.2010.08.032_bb0215","unstructured":"Seroquel\u00ae (quetiapine fumarate) tablets \u2014 US prescribing information. 2010. Available at: http:\/\/www1.astrazeneca-us.com\/pi\/seroquel.pdf (accessed January 18, 2010)."},{"key":"10.1016\/j.jad.2010.08.032_bb0220","first-page":"526","article-title":"Sleep and depression","volume":"103","author":"Slaughter","year":"2006","journal-title":"Mo. Med."},{"key":"10.1016\/j.jad.2010.08.032_bb0225","series-title":"Poster presented at the 48th Annual New Clinical Drug Evaluation Meeting, Phoenix, Arizona, USA, May 27\u201330","article-title":"Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression","author":"Suppes","year":"2008"},{"key":"10.1016\/j.jad.2010.08.032_bb0230","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4088\/JCP.v68n0207","article-title":"A randomized, double-blind comparison of olanzapine\/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder","volume":"68","author":"Thase","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2010.08.032_bb0235","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)","volume":"26","author":"Thase","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2010.08.032_bb0240","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S1092852900020307","article-title":"Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study","volume":"14","author":"Weisler","year":"2009","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2010.08.032_bb0245","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/13651500410005720","article-title":"A prospective randomized single-blind, multicenter trial comparing the efficacy and safety of paroxetine with and without quetiapine therapy in depression associated with anxiety","volume":"8","author":"Yargic","year":"2004","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.jad.2010.08.032_bb0250","first-page":"187","article-title":"A double-blind, placebo-controlled study with acute and continuation phase of quetiapine and lithium in adults with bipolar depression (EMBOLDEN I)","volume":"11","author":"Young","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032710005689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032710005689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:09:17Z","timestamp":1759021757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032710005689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":50,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0165032710005689"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2010.08.032","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2010.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}